Similarly, some chemotherapeutic drugs, such as gemcitabine, paclitaxel, have been shown to promote immune responses at tumor sites in a variety of ways in the treatment of other solid tumors, thereby synergistically interacting with PD-1/PD-L1 blockade. This evidence concerns the gene PDCD1 and neoplasm.